Virginie Girault

Virginie Girault

Auto-generated profile, based on publicly available information

Virginie Girault

Institute of Virology, School of Medicine and Health, Technical University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Nature
Verified
Journal Article
Closed access
PDF file
ASAlexey Stukalov
Alexey Stukalov
VGVirginie Girault
Virginie Girault
VGVincent Grass
Vincent Grass
OKOzge Karayel
Ozge Karayel
VBValter Bergant
Valter Bergant
APAndreas Pichlmair
Andreas Pichlmair

17 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAlexey Stukalov
Alexey Stukalov
VGVirginie Girault
Virginie Girault
VGVincent Grass
Vincent Grass
OKOzge Karayel
Ozge Karayel
VBValter Bergant
Valter Bergant
APAndreas Pichlmair
Andreas Pichlmair
Summary: The global emergence of SARS-CoV-2 urgently requires an in-depth understanding of molecular functions of viral proteins and their interactions with the host proteome. Several individual omics studies have extended our knowledge of COVID-19 pathophysiology 1–10 . Integration of such datasets to obtain a holistic view of virus-host interactions and to define the pathogenic properties of SARS-CoV-2 is limited by the heterogeneity of the experimental systems. We therefore conducted a concurrent multi-omics study of SARS-CoV-2 and SARS-CoV. Using state-of-the-art proteomics, we profiled the interactome of both viruses, as well as their influence on transcriptome, proteome, ubiquitinome and phosphoproteome in a lung-derived human cell line. Projecting these data onto the global network of cellular interactions revealed crosstalk between the perturbations taking place upon SARS-CoV-2 and SARS-CoV infections at different layers and identified unique and common molecular mechanisms of these closely related coronaviruses. The TGF-β pathway, known for its involvement in tissue fibrosis, was specifically dysregulated by SARS-CoV-2 ORF8 and autophagy by SARS-CoV-2 ORF3. The extensive dataset (available at https://covinet.innatelab.org ) highlights many hotspots that can be targeted by existing drugs and it can guide rational design of virus- and host-directed therapies, which we exemplify by identifying kinase and MMPs inhibitors with potent antiviral effects against SARS-CoV-2.

23 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
GGGloria Griffante
Gloria Griffante
FGFrancesca Gugliesi
Francesca Gugliesi
SPSelina Pasquero
Selina Pasquero
Dell'Oste ValentinaDell'Oste Valentina
Dell'Oste Valentina
Matteo BiolattiMatteo Biolatti
Matteo Biolatti
SLSanto Landolfo
Santo Landolfo
Citrullination is the conversion of arginine-to-citrulline by protein arginine deiminases (PADs), whose dysregulation is implicated in the pathogenesis of various types of cancers and autoimmune diseases. Consistent with the ability of human cytomegalovirus (HCMV) to induce post-translational modifications of cellular proteins to gain a survival advantage, we show that HCMV infection of primary human fibroblasts triggers PAD-mediated citrullination of several host proteins, and that this activity promotes viral fitness. Citrullinome analysis reveals significant changes in deimination levels of both cellular and viral proteins, with interferon (IFN)-inducible protein IFIT1 being among the most heavily deiminated one. As genetic depletion of IFIT1 strongly enhances HCMV growth, and in vitro IFIT1 citrullination impairs its ability to bind to 5’-ppp-RNA, we propose that viral-induced IFIT1 citrullination is a mechanism of HCMV evasion from host antiviral resistance. Overall, our findings point to a crucial role of citrullination in subverting cellular responses to viral infection.

30 July 2025 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
VGVirginie Girault
Virginie Girault
ASAlexey Stukalov
Alexey Stukalov
MCMadalina Elena Carter-Timofte
Madalina Elena Carter-Timofte
JHJonny Hertzog
Jonny Hertzog
MVMelissa Verin
Melissa Verin
APAndreas Pichlmair
Andreas Pichlmair
Varicella-zoster virus (VZV) infects most humans and causes chickenpox, shingles and central nervous system pathologies. The molecular basis for these phenotypes remains elusive. Here we conducted a multi-proteomic survey on 64 individual VZV proteins and infection-induced perturbations in a neuronal cell line, identifying 900 interactors and 3,618 regulated host proteins. Data integration suggested molecular functions of viral proteins, such as a mechanism for the ORF61-mediated IFI16 degradation via the recruitment of E3 ligase co-factors. Moreover, we identified proviral host factors (MPP8 and ZNF280D) as potential targets to limit infection. Integration of exome sequencing analysis from patients with VZV-associated central nervous system pathologies identified nephrocystin 4 as a viral restriction factor, and its S862N variant, which showed reduced activity and decreased binding to the regulatory proteins 14-3-3. Collectively, our study provides a comprehensive herpesvirus–host interface resource, which aids our understanding of disease-associated molecular perturbations and data-driven identification of antiviral treatment options.